Seo, An Na <br/><br/>
FGFR1 amplification is associated with poor prognosis and smoking in non-small-cell lung cancer.  [electronic resource] 

 -  Virchows Archiv : an international journal of pathology  Nov 2014 
 - 547-58 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1432-2307 
<br/><br/><label>Standard No.: </label>10.1007/s00428-014-1634-2  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenocarcinoma--pathology<br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Carcinoma, Non-Small-Cell Lung--genetics<br/>Carcinoma, Squamous Cell--pathology<br/>Disease-Free Survival<br/>Female<br/>Gene Amplification<br/>Gene Dosage<br/>Humans<br/>In Situ Hybridization, Fluorescence<br/>Lung Neoplasms--genetics<br/>Male<br/>Middle Aged<br/>Prognosis<br/>Receptor, Fibroblast Growth Factor, Type 1--biosynthesis<br/>Retrospective Studies<br/>Smoking